ArticleFrontiers in oncology2021

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma.

Junyu Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.